Search for: "Wyeth Pharmaceuticals"
Results 621 - 640
of 971
Sorted by Relevance
|
Sort by Date
3 Feb 2014, 5:00 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
18 Jan 2007, 7:53 pm
Wyeth-Ayerst Labs., 82 S.W.3d 849, 857 (Ky. 2002); Hinton v. [read post]
27 Apr 2010, 4:30 am
For example, when the Court found no implied preemption in the pharmaceutical labeling case, Wyeth v. [read post]
15 Oct 2008, 3:02 pm
The Supreme Court wil shortly hear these arguments in the context of a drug case and FDA preamble that attempts to grant immunity, when Wyeth v. [read post]
21 May 2015, 1:09 pm
Second, the Court rejected an almost identical pre-approval argument in Wyeth v. [read post]
5 Jul 2007, 10:37 am
App. 2000); Wyeth-Ayerst Laboratories Co. v. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
24 Jan 2008, 12:25 pm
The Wyeth v. [read post]
28 Aug 2014, 7:42 am
Reglan, also known as metoclopramide, was first marketed as a brand name drug in the early 1970s by Wyeth. [read post]
19 Mar 2012, 1:31 am
Wyeth, No. 08-1-349K (Cir. [read post]
22 Feb 2008, 1:30 pm
Nonetheless, the administration is arguing in the case the court has accepted for its next term, Wyeth v. [read post]
29 Dec 2011, 6:53 am
Wyeth Pharmaceuticals, 797 F. [read post]
24 Aug 2015, 5:00 am
Wyeth Pharmaceuticals, 797 F. [read post]
19 Jun 2008, 12:00 pm
So we missed two - there were also amicus briefs filed by DRI (we should have known those guys wouldn't miss this party) and by the Generic Pharmaceutical Association. [read post]
19 Mar 2013, 6:01 am
In Wyeth v Levine, the Court pointed out that “Congress did not intend FDA oversight to be the exclusive means of ensuring drug safety and effectiveness’ and that state law serves as a ‘complementary form of drug regulation. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs) Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
20 Sep 2011, 6:35 am
Wyeth, Inc., ___ F.3d ___, 2011 WL 4389211, slip op. (6th Cir. [read post]
30 Jul 2009, 11:32 am
v=dum81RdFrhM&feature=player_embedded Unfortunately, both the manufacturer of Reglan (Wyeth Pharmaceuticals) and manufacturers of the generic metoclopramide (Actavis Elizabeth, Teva Pharmaceuticals USA, Pliva and Barr Pharmaceuticals) have placed profits before patient safety. [read post]
29 Jun 2011, 5:00 am
The doctrine constitutes a defense by pharmaceutical manufacturers in cases where a plaintiff has suffered injury from a medication prescribed by a doctor. [read post]
23 Jul 2010, 7:28 am
Mutual Pharmaceutical Co., 659 F. [read post]
